Figure 1From: Evaluation of reactive oxygen metabolites in patients with non-small cell lung cancer after chemotherapyROMs levels (U. CARR) in control subjects and in patients with non-small cell lung cancer before treatment. Data are expressed as mean ± SD. ROMs level was elevated significantly in patients before treatment compared with the control subjects (p = 0.016, unpaired t-test).Back to article page